NCT00329121View on ClinicalTrials.gov

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Carcinoma, Squamous Cell
Interventions
DRUG

PEP005

Trial Locations (3)

2217

Southderm Pty Ltd, Kogarah

4000

Siller Medical, Brisbane

4217

The Skin Centre, Benowa

Sponsors

Lead Sponsor

Peplin
All Listed Sponsors
lead

Peplin

INDUSTRY

NCT00329121 - Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ | Biotech Hunter | Biotech Hunter